GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

OK Biotech Co 4155.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

18.50

+3.35%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 1.56bn

FY2016FY2025

Net income

TWD 82.4m

FY2016FY2025

Free cash flow

−TWD 89.6m

FY2016FY2025

Shareholders' equity

TWD 2.51bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 1.56bnTWD 1.67bnTWD 1.19bnTWD 1.48bnTWD 1.26bnTWD 1.48bnTWD 1.24bnTWD 1.12bnTWD 1.23bnTWD 1.04bn
Research and developmentTWD 59.0mTWD 57.9mTWD 46.7mTWD 48.7mTWD 28.7mTWD 45.5mTWD 32.6mTWD 40.8mTWD 32.6mTWD 20.2m
Operating incomeTWD 107.9mTWD 57.2mTWD 11.7mTWD 211.6mTWD 49.3mTWD 170.1mTWD 147.5mTWD 147.0mTWD 122.3mTWD 108.3m
Net incomeTWD 82.4mTWD 94.0mTWD 2.9mTWD 143.5mTWD 31.4mTWD 129.7mTWD 125.8mTWD 161.4mTWD 126.8mTWD 85.2m
Diluted earnings per share0.520.640.021.290.271.471.672.081.921.35

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 3.85bnTWD 3.70bnTWD 3.07bnTWD 3.06bnTWD 2.81bnTWD 2.54bnTWD 2.22bnTWD 1.85bnTWD 1.88bnTWD 1.50bn
Cash and short-term investmentsTWD 327.1mTWD 290.5mTWD 365.3mTWD 636.6mTWD 644.6mTWD 566.7mTWD 332.3mTWD 184.4mTWD 455.7mTWD 164.3m
Total liabilitiesTWD 1.27bnTWD 1.13bnTWD 672.3mTWD 1.21bnTWD 1.11bnTWD 795.9mTWD 918.4mTWD 582.7mTWD 678.1mTWD 550.6m
DebtTWD 1.03bnTWD 779.4mTWD 333.0mTWD 780.6mTWD 735.7mTWD 305.3mTWD 534.1mTWD 258.8mTWD 386.0mTWD 291.0m
Shareholders' equityTWD 2.51bnTWD 2.49bnTWD 2.40bnTWD 1.84bnTWD 1.70bnTWD 1.73bnTWD 1.29bnTWD 1.25bnTWD 1.21bnTWD 944.8m
Shares outstanding157m146m146m111m116m88m75m77m66m63m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 319.6mTWD 65.9mTWD 2.9mTWD 240.5mTWD 21.9mTWD 147.7mTWD 45.2mTWD 128.8mTWD 102.8mTWD 260.7m
Capital spending−TWD 409.1m−TWD 374.7m−TWD 437.1m−TWD 294.2m−TWD 86.5m−TWD 79.8m−TWD 78.0m−TWD 28.4m−TWD 88.0m−TWD 57.0m
Free cash flow−TWD 89.6m−TWD 308.8m−TWD 434.1m−TWD 53.7m−TWD 64.6mTWD 67.9m−TWD 32.8mTWD 100.4mTWD 14.7mTWD 203.7m
Dividends paid−TWD 43.8m−TWD 44.1m−TWD 144.6m−TWD 94.9m−TWD 131.8m−TWD 112.1m−TWD 166.4m−TWD 111.3m−TWD 100.4m−TWD 100.2m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 436.1mTWD 383.8mTWD 337.6mTWD 379.6mTWD 426.8mTWD 412.4mTWD 420.7mTWD 458.3m
Operating incomeTWD 51.7mTWD 60.1mTWD 59.2mTWD 53.9mTWD 17.7mTWD 23.2mTWD 35.7m−TWD 21.8m
Net incomeTWD 48.2mTWD 55.4mTWD 53.5mTWD 85.2m−TWD 81.1mTWD 24.8mTWD 39.8m−TWD 24.2m
Diluted earnings per share0.340.390.340.54-0.520.160.27-0.17
Cash from operationsTWD 126.0mTWD 59.0mTWD 256.0mTWD 47.0m−TWD 15.0mTWD 35.0mTWD 28.0m−TWD 92.0m
Capital spending−TWD 33.0m−TWD 54.0m−TWD 94.0m−TWD 50.0m−TWD 123.0m−TWD 141.0m−TWD 77.0m−TWD 183.0m
Free cash flowTWD 93.0mTWD 5.0mTWD 162.0m−TWD 3.0m−TWD 138.0m−TWD 106.0m−TWD 49.0m−TWD 275.0m
Total assetsTWD 3.99bnTWD 3.89bnTWD 3.85bnTWD 3.89bnTWD 3.67bnTWD 3.82bnTWD 3.70bnTWD 3.43bn
Cash and short-term investmentsTWD 382.9mTWD 318.0mTWD 327.1mTWD 315.8mTWD 177.7mTWD 314.8mTWD 290.5mTWD 192.8m
DebtTWD 961.9mTWD 941.9mTWD 954.0mTWD 1.12bnTWD 911.0mTWD 864.7mTWD 745.7mTWD 579.9m
Shareholders' equityTWD 2.52bnTWD 2.53bnTWD 2.51bnTWD 2.46bnTWD 2.38bnTWD 2.48bnTWD 2.49bnTWD 2.45bn

Financial ratios

Data as of 30 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin6.9%8.0%1.0%12.1%2.3%8.2%
Net margin5.3%5.6%0.2%9.7%2.5%8.7%
Return on equity3.3%3.8%0.1%7.8%1.8%7.5%
Return on assets2.1%2.5%0.1%4.7%1.1%5.1%
Free cash flow yield27.6%17.9%18.0%28.6%5.5%15.4%
Revenue growth-6.8%40.1%-19.7%17.4%-14.9%19.6%
Earnings growth-12.3%3087.8%-97.9%356.6%-75.8%3.2%
Current ratio2.28x1.98x2.28x1.84x2.13x1.95x
Debt to equity0.38x0.30x0.14x0.42x0.43x0.26x
Equity ratio65.3%67.4%78.2%60.3%60.6%68.2%
Interest coverage9.88x21.40x1.30x15.72x3.66x14.92x
R&D as a share of sales3.8%3.5%3.9%3.3%2.3%3.1%
Buybacks as a share of market value-7.4%-0.3%-30.8%4.1%-32.1%-16.7%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue1.6%1.0%6.2%
Operating income-20.1%-8.7%-0.5%
Net income-16.9%-8.7%-2.9%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin5.1%6.6%7.0%8.8%
Net margin5.5%5.5%5.6%7.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings30.835.5—21.787.518.519.711.715.520.8
Price to sales1.62.03.42.12.21.62.01.71.61.7

Dividends and splits

Per share, in the currency the company pays

Paid for 15 years. Last went ex-dividend on 4 Jul 2025.

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Paid in the year0.3350.3351.3720.9891.3741.422.1741.426
  • 1.102-for-1 split · 6 Sept 2023
  • 1.03-for-1 split · 2 Jul 2018
  • 13-for-10 split · 29 Jul 2013
  • 1.19-for-1 split · 11 Jun 2012
  • 29-for-25 split · 21 Jun 2011

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.